Form 4: Bristol-Myers Squibb Executive Samit Hirawat Acquires Shares

EVP, Chief Medical Officer, Drug Development at Bristol-Myers Squibb, Samit Hirawat, purchased 1,830 shares of BMY stock at $54.675 per share on November 1, 2024.

Summary

• On November 1, 2024, Samit Hirawat, EVP, Chief Medical Officer, Drug Development at Bristol-Myers Squibb, acquired 1,830 shares of common stock at a price of $54.675 per share.
• Following this transaction, Hirawat directly owns 62,109 shares of Bristol-Myers Squibb common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects an executive's decision to invest in their own company, which can be seen as a vote of confidence, but it's a routine transaction.

Positives

• The purchase of shares by an executive could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Industry Context

Executive stock purchases are common and are often viewed as a sign of confidence in the company's performance and future.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates